Pakistan Floods
Pakistan: “These floods will likely affect the population for months”
Jharkhand: fighting malnutrition alongside local communities

MSF Community Health Educator Subashini Deb Mahto shares her first-hand experience of malnutrition.

Pakistan: “These floods will likely affect the population for months”

Monsoon rains have plagued Pakistan for months and have become yet more intense in recent weeks, causing widespread damage in much of the country, increased by global warming and the melting of glaciers. Millions of people have lost their homes and are being forced to sleep in makeshift shelters, while many health structures are damaged or not functioning. MSF teams are stepping up their support to people affected by the situation and are preparing to intervene quickly in case of outbreaks.

©MSF
©MSF
Pakistan Floods
Pakistan: “These floods will likely affect the population for months”
Jharkhand: fighting malnutrition alongside local communities

MSF Community Health Educator Subashini Deb Mahto shares her first-hand experience of malnutrition.

Global TB Report 2022: MSF calls for scale up of shorter and safer DR-TB treatments to help save more lives

The World Health Organization (WHO) has released the 2022 edition of its Global Tuberculosis (TB) Report, featuring data on the TB response and trends in 215 countries and areas. Among the alarming trends from 2021, there is an increase in the estimated incidence of TB for the first time in two decades, including for the more difficult to treat form of this disease, drug-resistant TB (DR-TB).

The World Health Organization (WHO) has released the 2022 edition of its Global Tuberculosis (TB) Report, featuring data on the TB response and trends in 215 countries and areas. Among the alarming trends from 2021, there is an increase in the estimated incidence of TB for the first time in two decades, including for the more difficult to treat form of this disease, drug-resistant TB (DR-TB).

©MSF
©MSF
MSF recommends WHO
MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB
Jharkhand: fighting malnutrition alongside local communities

MSF Community Health Educator Subashini Deb Mahto shares her first-hand experience of malnutrition.

MSF responds to new WHO guidance recommending vastly shorter, improved and better-tolerated treatment for multi drug-resistant TB

Following the results of MSF’s trial the WHO are now recommending programmatic use of the 6-month BPaLM regimen – comprising bedaquiline, pretomanid, linezolid (600 mg) and moxifloxacin in MDR-TB patients in place of longer, existing regimens. WHO are also recommending another shorter treatment; the BPaL combination in patients with increased drug-resistance as both regimens showed high treatment success.

©MSF
©MSF

MSF - An international, independent medical humanitarian organisation

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistics and administrative staff – most of them hired locally. Our actions are guided by medical ethics and the principles of impartiality, independence and neutrality.

Slide One

Founded in 1971

Slide One
Slide two

Awarded Nobel Peace Prize in 1999

Slide two
 

Projects in South Asia

Afghanistan

Afghanistan

View project
Bangladesh

Bangladesh

View project
India

India

View project
Pakistan

Pakistan

View project


Access Campaign

Medicines shouldn’t be a luxury

MSF launched Access Campaign with a purpose to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond.

Get Involved

Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons